... Dasatinib (Phyrago, Sprycel) and nilotinib (Tasigna) and — These drugs are FDA-approved to treat some cases of CML, particularly for individuals who become resistant to first-line therapy. ...
... Dasatinib (Phyrago, Sprycel) and nilotinib (Tasigna) and — These drugs are FDA-approved to treat some cases of CML, particularly for individuals who become resistant to first-line therapy. ...